Abstract: Disclosed are methods for preparing a salt of urolithin A and, in turn, urolithin A. The methods are advantageous for the large-scale preparation of urolithin A or a pharmaceutically acceptable salt thereof.

Abstract: Provided herein are systems and methods for determining if a 3D tooth model requires trimming or removal of incomplete or missing data (e.g., gingiva covering a portion of a tooth such as a molar). A patient's dentition may be scanned and/or segmented. Raw dental features, principal component analysis (PCA) features, and/or other features may be extracted and compared to those of other teeth, such as those obtained through automated machine learning systems. A classifier can identify and/or output probability that the 3D tooth model requires trimming. Trimming of the 3D tooth model can be implemented without human intervention.

Abstract: A temperature sensitive coating for application on a surface is provided. The temperature sensitive coating comprises an indicator component. The indicator component includes a carrier and a releasable compound that is held by the carrier. The releasable compound is in a gas state at a critical release temperature, and is released from the carrier at a temperature that is at or above the critical release temperature. A method of coating a surface of an energy storage system, and a method of detecting the approach of thermal runaway of an energy storage system, are also provided. The method includes coating a surface with the temperature sensitive coating, providing a gas sensor in the vicinity of the surface that is capable of detecting the presence of the releasable compound, monitoring the output of the sensor, and signaling an alarm when the sensor output indicates the presence of the releasable compound.

Abstract: Provided herein are systems and methods for determining if a 3D tooth model requires trimming or removal of incomplete or missing data (e.g., gingiva covering a portion of a tooth such as a molar). A patient's dentition may be scanned and/or segmented. Raw dental features, principal component analysis (PCA) features, and/or other features may be extracted and compared to those of other teeth, such as those obtained through automated machine learning systems. A classifier can identify and/or output probability that the 3D tooth model requires trimming. Trimming of the 3D tooth model can be implemented without human intervention.

Abstract: A method for collaboration using a cell-based computational notebook is described. The method includes receiving a cell on a first computer from the cell-based computational notebook, the cell including executable code, the executable code including variables. The method further includes executing the executable code in the cell to generate a result and saving in a storage medium a state of the cell, the state of the cell including values of the variables associated with the executable code in the cell and the result. A system implementing the method is also disclosed.

Abstract: Disclosed are methods for preparing a salt of urolithin A and, in turn, urolithin A. The methods are advantageous for the large-scale preparation of urolithin A or a pharmaceutically acceptable salt thereof.

Abstract: A system and method includes a blockchain operation stack which may control access to reading and writing operations for a blockchain. The blockchain operation stack may include a credential authority layer that may control permissions for profiles maintained by the credential authority layer. When the permissions are granted by the credential authority layer, a presentation layer may generate a display that may include information on the blockchain structure. Integrity outputs stored in a successor block may verify that a predecessor block has been rewritten and is valid. The presentation layer may provide tools to facilitate write layer operations to rewrite and append to the blockchain.

Abstract: A method of generating a horizon for use by an ADAS of a vehicle involves using digital location-based data, driver data and/or vehicle data to determine the likelihood that different outgoing paths are taken at a decision point along a currently traversed road segment, and deriving a probability that each path may be taken. The probability may be based on one or more of: an angle of the path relative to the incoming path, the road class of the path, a speed profile of the path, historical paths taken by vehicles at the decision point, and historical paths taken at the decision point by the individual driver or vehicle.

Abstract: A method for operating a motor vehicle, which includes a drive system, including an electric drive machine, a friction braking system and an actuating element. The actuating element is continuously movable between a first end state and a second end state, a position of the actuating element in the first end state corresponding to a percentage value of 0%, and the position of the actuating element in the second end state corresponding to a percentage value of 100%. An acceleration torque for the motor vehicle is predefined if the positon has a percentage value that is greater than a predefined threshold value, and a deceleration torque for the motor vehicle being predefined if the position has a percentage value that is less than the threshold value. The friction braking system is activated in such a way that the friction braking system generates at least partially the predefined deceleration torque.

Abstract: A method and medical preparation for enhancing tissue oxygenation by suppression of a hypoxia induced factor 1? (HIF-1?) in case of low oxygen tension in a tissue of a diabetic foot in a patient with type I or type II diabetes mellitus, wherein the method includes administering a dipeptide of L-glutamic acid-L-tryptophan (L-Glu-L-Trp), and wherein the medical preparation includes an effective amount of the dipeptide of L-Glu-L-Trp as an active agent and a pharmaceutically acceptable carrier. Moreover, the method can include administering the medical preparation in a dose of 1.0 ?g per kg-10.0 ?g per kg of body weight at least once a day for a period necessary to achieve a therapeutic effect.

Abstract: Disclosed are methods for preparing a salt of urolithin A and, in turn, urolithin A. The methods are advantageous for the large-scale preparation of urolithin A or a pharmaceutically acceptable salt thereof.

Abstract: A spacecraft includes a power train that includes a solar array, an electric propulsion subsystem, and a power conversion module. The power conversion module receives power from the solar array at a voltage, Vi; and delivers power to the electric propulsion subsystem at a voltage, Vo. The spacecraft is configured to operate at a varying distance, D, from the sun within the range of Dmin to Dmax, Dmax being at least 1.3×Dmin. The solar array is configured to deliver power to the power conversion module at a voltage approximately equal to Vo when the spacecraft is proximate to Dmax.

Abstract: Disclosed are methods for preparing a salt of urolithin A and, in turn, urolithin A. The methods are advantageous for the large-scale preparation of urolithin A or a pharmaceutically acceptable salt thereof.

Abstract: Controlling a mixed reality (MR), virtual reality (VR), or augmented reality (AR) (collectively, MR) environment visualization may involve obtaining a plurality of sensor data from a plurality of data sources; processing the obtained plurality of sensor data using a plurality of data analyzers to identify at least one feature; generating a plurality of annotated data sets, wherein the annotated data sets contain an annotation of the at least one feature; aggregating the plurality of annotated data sets to correlate the at least one feature as a common feature across different annotated data sets of the plurality of annotated data sets; and based at least on the common feature, providing a visualization output representing the MR (VR, AR, or specifically mixed-reality) environment. Disclosed examples enable utilizing of disparate data types from different data sources, localizing the different data a common space, and aggregating results for visualization and/or further analysis.

Abstract: A system includes a blockchain operation stack which may control access to reading and writing operations for a blockchain. The blockchain operation stack may include a credential authority layer that may control permissions for profiles maintained by the credential authority layer. When the permissions are granted by the credential authority layer, a presentation layer may generate a display that may include information on the blockchain structure. The presentation layer may provide tools to facilitate write layer operations to rewrite and append to the blockchain.

Abstract: Controlling a mixed reality (MR), virtual reality (VR), or augmented reality (AR) (collectively, MR) environment visualization may involve obtaining a plurality of sensor data from a plurality of data sources; processing the obtained plurality of sensor data using a plurality of data analyzers to identify at least one feature; generating a plurality of annotated data sets, wherein the annotated data sets contain an annotation of the at least one feature; aggregating the plurality of annotated data sets to correlate the at least one feature as a common feature across different annotated data sets of the plurality of annotated data sets; and based at least on the common feature, providing a visualization output representing the MR (VR, AR, or specifically mixed-reality) environment. Disclosed examples enable utilizing of disparate data types from different data sources, localizing the different data a common space, and aggregating results for visualization and/or further analysis.

Abstract: The present invention proposes a new use of dipeptide L-glutamic-L-tryptophan acid (L-Glu-L-Trp) for enhancing tissue oxygenation by suppression (reducing a synthesis) of HIF-1? factor in case of diabetic foot, a medical preparation including an effective amount of the dipeptide L-Glu-L-Trp as an active agent and a pharmaceutically acceptable carrier, and a method of treating a diabetic foot including locally administering the mentioned medical preparation comprising the dipeptide L-Glu-L-Trp in a dose of 1.0 ?g per kg-10.0 ?g per kg of body weight at least once a day for a period necessary to achieve a therapeutic effect. The technical result of invention includes providing a peptide preparation, which exerts an antihypoxic effect in diabetes mellitus of both types.

Abstract: Controlling a mixed reality (MR), virtual reality (VR), or augmented reality (AR) (collectively, MR) environment visualization may involve obtaining a plurality of sensor data from a plurality of data sources; processing the obtained plurality of sensor data using a plurality of data analyzers to identify at least one feature; generating a plurality of annotated data sets, wherein the annotated data sets contain an annotation of the at least one feature; aggregating the plurality of annotated data sets to correlate the at least one feature as a common feature across different annotated data sets of the plurality of annotated data sets; and based at least on the common feature, providing a visualization output representing the MR (VR, AR, or specifically mixed-reality) environment. Disclosed examples enable utilizing of disparate data types from different data sources, localizing the different data a common space, and aggregating results for visualization and/or further analysis.

Abstract: Provided herein are systems and methods for determining if a 3D tooth model requires trimming or removal of incomplete or missing data (e.g., gingiva covering a portion of a tooth such as a molar). A patient's dentition may be scanned and/or segmented. Raw dental features, principal component analysis (PCA) features, and/or other features may be extracted and compared to those of other teeth, such as those obtained through automated machine learning systems. A classifier can identify and/or output probability that the 3D tooth model requires trimming. Trimming of the 3D tooth model can be implemented without human intervention.

Abstract: A method of generating a horizon for use by an ADAS of a vehicle involves using digital location-based data, driver data and/or vehicle data to determine the likelihood that different outgoing paths are taken at a decision point along a currently traversed road segment, and deriving a probability that each path may be taken. The probability may be based on one or more of: an angle of the path relative to the incoming path, the road class of the path, a speed profile of the path, historical paths taken by vehicles at the decision point, and historical paths taken at the decision point by the individual driver or vehicle.